Company Filing History:
1 out of 453 
1 out of 45 
1 out of 13 Years Active: 2015
Title: Abdelouahid Samadi: Innovator in Neuroprotective Compounds
Introduction
Abdelouahid Samadi is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of neuroprotective compounds, particularly in the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's. His innovative work has led to the development of a unique compound that holds promise for improving the lives of those affected by these conditions.
Latest Patents
Samadi holds a patent for "Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases." This invention relates to a compound of formula (I), where various components are selected from specific groups to create a compound that can be used in pharmaceutical compositions for treating neurodegenerative diseases. The patent highlights the potential of these compounds in providing therapeutic benefits for patients suffering from Alzheimer's and Parkinson's diseases.
Career Highlights
Throughout his career, Abdelouahid Samadi has worked with esteemed institutions such as the Consejo Superior de Investigaciones Científicas and Universitat Autònoma de Barcelona. His experience in these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in the field of neuroprotection.
Collaborations
Some of his notable coworkers include José Luis Marco Contelles and Irene Bolea Tomás. Their collaborative efforts have further advanced the research and development of neuroprotective compounds.
Conclusion
Abdelouahid Samadi's innovative work in the field of neuroprotective compounds showcases his dedication to addressing critical health challenges. His contributions have the potential to make a significant impact on the treatment of neurodegenerative diseases.